Lemaitre Vascular (LMAT) Tops Q3 EPS by 5c ; Offers Guidance

Lemaitre Vascular (NASDAQ: LMAT) reported Q3 EPS of $0.62, $0.05 better than the analyst estimate of $0.57. Revenue for the quarter came in at $61 million versus the consensus estimate of $62.23 million.

GUIDANCE:

Lemaitre Vascular sees Q4 2025 EPS of $0.64-$0.69, versus the consensus of $0.63. Lemaitre Vascular sees Q4 2025 revenue of $61.8-63.8 million, versus the consensus of $62.17 million.

Lemaitre Vascular sees FY2025 EPS of $2.48-$2.53, versus the consensus of $2.28. Lemaitre Vascular sees FY2025 revenue of $247-249 million, versus the consensus of $250.6 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• Google: Introducing Gemini 4 Argon
• Trinity Capital prices $350M note offering at 7.50% due 2032
• Synopsys sets fiscal 2027 revenue target of $11.15B at investor day